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Background: Malignant adenomyoepithelioma and adenoid cystic carcinoma are both rare malignant
epithelial-myoepithelial tumors of the breast. We report a very rare case with a malignant adenomyoepithelioma
combining with adenoid cystic carcinoma in a single mass.
Case presentation: A 61-year-old female presented with a palpable painless mass in the right breast. Mammography
revealed a large irregular dense shadow without obvious internal calcification. A simple lumpectomy was performed,
and a 1.6cm well-circumscribed pale-tan nodule was presented. Histologically, the nodule was composed of two
obscure lobules. One exhibited typical histological image of adenoid cystic carcinoma, the other one showed the
image of epithelial-myoepithelial carcinoma of salivary gland, and support the diagnosis of biphasic malignant
adenomyoepithelioma. Transition between the two lobules was gradual. Immunohistochemically, CK18 and P63
highlighted the epithelial and myoepithelial cells respectively in both lesions. CD117 was positive in the epithelial
cells of adenoid cystic carcinoma, but was totally negative in malignant adenomyoepithelioma.
Conclusion: This report is, to our knowledge, the first case that combines these two tumors in a single mass.
In addition, we present a review of the literature. The histogenesis of these tumors is also discussed.
Virtual Slides: The virtual slide(s) for this article can be found here: http://med.motic.com/MoticGallery/Slide?id=D562817E-
23C2-4F72-9823-86EF6DA40005&user=2C69F0D6-A478-4A2B-ABF0-BB36763E8025 and http://med.motic.com/MoticGallery/
Slide?id=38BB7126-6FFB-4B66-A208-B8C0F528DCA8&user=2C69F0D6-A478-4A2B-ABF0-BB36763E8025
Keywords: Breast, Adenomyoepithelioma, Adenoid cystic carcinomaBackground
Malignant adenomyoepithelioma (AME) and adenoid cystic
carcinoma (ACC) are both rare malignant epithelial-
myoepithelial lesions of the breast. There are no more than
50 documented cases for the former [1], and the latter con-
stitutes about 0.1% of all breast tumors [2]. Difficulties are
commonly encountered in diagnosis and differential diag-
nosis because of the rarity and similarity of these two tu-
mors. Composed of epithelial and myoepithelial cells,
these two salivary gland-like tumors of the breast are mor-
phologically close. However, the relationship of them was
seldom observed. There is only one report of adenoid* Correspondence: bianli1976@sina.com
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so far [3].To the best of our knowledge, what we present
herein is the first case that combines malignant adeno-
myoepithelioma and adenoid cystic carcinoma in a single
mass. The aim of this report is to analyze the histological
and immunohistochemical features of the two tumors by
comparing each other, conclude the method of differential
diagnosis, and most importantly, apply clue to the genesis
of epithelial-myoepithelial tumors.
Case presentation
A 61-year-old female was admitted to The First Affiliated
Hospital of Kunming Medical University, Yunnan, China,
complaining of a lump in the right breast which had
appeared 2 days earlier and had been increasing in tender-
ness for a week. During the physical examination, the pa-
tient’s breasts were found to be bilaterally symmetrical,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Imaging inspection. Mammography revealed a small
irregular dense shadow in the upper outer quadrant of the right
breast.
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same horizontal line without discharge nor retraction. A
mass was palpable in the upper-outer quadrant about 5
cm away from the right nipple, with an approximate size
of 1.5 cm × 1 cm. The mass was tough in texture, irregular
in shape, unclear in boundary and slightly adhesive to the
surrounding tissues. There were no positive findings in
the left breast. The superficial lymph nodes were not palp-
able in the bilateral axillary and clavicular fossa. The pa-
tient had no history of smoking or alcohol consumption
and there was no family history of any types of tumor.
Ultrasonography revealed an ill-defined mass in the
right breast, and its internal echo was non-homogenous.
Mammography revealed a small irregular dense shadow
in the upper outer quadrant of the right breast (Figure 1).
The boundary of the shadow was unclear and the glands
around were gathered without obvious internal calci-
fication. The emission computed tomography (ECT) of
whole-body bone imaging and the CT of brain, liver and
lung imaging showed no signs of tumor metastasis.
Evaluation of tumor markers showed that serum carbo-
hydrate antigen (CA) CA 15–3 was 37.6 U/ml (the nor-
mal range is 0–35 U/ml). Other tumor markers were
within normal ranges. A simple lumpectomy was per-
formed in the hospital.
Grossly, the well-circumscribed pale-tan nodule mea-
sured 1.6cm × 1.2cm × 0.5cm and lacked a distinct cap-
sule. Histologically, the nodule was composed of two
obscure lobules without evidence of a capsule on low-
power examination (Figure 2). One of the lobules con-
sisted of small tubular ducts formed by two phenotypically
distinct cell layers. The inner epithelial cells exhibited
eosinophilic cytoplasm and the outer myoepithelial cells
were clear. Tubular structures predominated in this lobule
and formed an expansile circumscribed, partially-encap-
sulated mass, although focally infiltrated into adjacent fat
tissue (Figure 2). A papillary component was also noted in
some areas. In addition, atypia was obvious in both epi-
thelial and myoepithelial cells with moderate degree of
nuclear pleomorphism, prominent nucleoli, high nuc-
lear cytoplasmic ratio and increased mitotic figures
(11/10HPF) (Figure 3). These histological features support
the diagnosis of malignant adenomyoepithelioma.
The other lobule of the mass exhibited typical histo-
logical image of adenoid cystic carcinoma which consisted
of tubular and cribriform structure and had infiltrative bor-
ders. The epithelial and myoepithelial cells, whose diffe-
rence was not as obvious as in adenomyoepithelioma, were
polarized around two types of spaces: true glandular spaces
(contain mucoid material) and pseudolumens (contain
basement membrane material) (Figure 4). The myoepithe-
lial cells of adenoid cystic carcinoma were smaller, had a
more hyperchromatic and basaloid character and had
much less cytoplasm than those of adenomyoepithelioma,and the invagination of stroma was frequently present.
Transition from adenomyoepithelioma to adenoid cystic
carcinoma was gradual. And we can also see adenomyoe-
pithelioma and adenoid cystic carcinoma combined in
some areas.
Immunohistochemistry can distinguish the two dif-
ferent cell types. In both lesions, the myoepithelial cells
were highlighted by CK5/6, smooth muscle actin (SMA)
and p63, while the epithelial cells were positive for
CK18 (Figure 5). Immunostains for estrogen (ER) and
Figure 2 Low-power examination. The nodule was composed of
two obscure lobules on low-power examination. The left one was
adenoid cystic carcinoma and the right one was malignant
adenomyoepithelioma. HE, ×10. Figure 4 High-power examination to the adenoid cystic
carcinoma. The cribriform structure in adenoid cystic carcinoma
contains true glandular spaces and pseudolumens. HE, ×200.
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positive in surrounding normal ductal epithelial, and
human epidermal growth factor receptor 2 (Her2) were
also negative in this case. Nevertheless, CD117 expression
was found in adenoid cystic carcinoma in contrast to
adenomyoepithelioma, where CD117 was not expressed
(Figure 5).
A modified radical mastectomy was performed accor-
ding to the pathology results, the patient’s economic si-
tuation and with the patient’s consent. No lymph nodes
involvement was found (0/21). The margins, basement
membrane and nipple were all free of metastasis. Chemo-
therapy and radiation therapy were not indicated and the
patient remained in a good condition throughout the
12-month follow-up period.Figure 3 High-power examination to the malignant
adenomyoepithelioma. Atypia was obvious in both epithelial and
myoepithelial cells with moderate degree of nuclear pleomorphism,
prominent nucleoli, high nuclear cytoplasmic ratio and increased
mitotic figures (arrow). HE, ×200.Discussion
Adenomyoepithelioma is usually a benign neoplasm with
a low metastatic potential. However, the malignant trans-
formation can arise from the epithelial component, the
myoepithelial component, or both. There are no well-
received criteria for malignant adenomyoepithelioma be-
cause of the rarity of this lesion. According to the growth
pattern of malignant components, the cases reported in
the literatures can be divided into two types: 1) an area
of obvious malignant component arising in a typical
low-grade adenomyoepithelioma, which may be more
appropriately named “adenomyoepithelioma with carci-
noma” as defined in the 4th edition of WHO Classification
of Tumours of the Breast [4], or “carcinoma arising in
adenomyoepithelioma”; 2) an adenomyoepithelioma with
apparent cytological atypia, increased mitotic activity
(>5/10HPFs), invasive growth pattern, and/or presence of
necrosis in both epithelial and myoepithelial cells as the
histological image of the current case, reminiscent of
epithelial-myoepithelial carcinoma of salivary glands [5,6].
This type was named by Marian et al. as “atypical adeno-
myoepithelioma” [1] and may be more appropriately
named “epithelial-myoepithelial carcinoma of the breast”
in our opinion. Base on the differentiation of the malig-
nancy, the tumors can be divided into monophasic and
biphasic. The monophasic malignancy could be invasive
ductal carcinoma not otherwise specified, metaplastic car-
cinoma, low-grade adenosquamous carcinoma [5], inva-
sive lobular carcinoma [7], and ductal carcinoma in situ
[8,9] which arising from epithelial component, or malig-
nant myoepithelioma [1] which arising from myoepithelial
component. Only 16 biphasic malignant adenomyoepithe-
liomas in which malignancy arising from both epithelial
and myoepithelial cells have been reported previously
[5,6,10-17] (Table 1), and our current case is another one.
Figure 5 The immunohistochemistry panel of malignant adenomyoepithelioma (A, B, C) and adenoid cystic carcinoma (D, E, F). CK18
was expressed in epithelial cells of malignant adenomyoepithelioma (A) and adenoid cystic carcinoma (D). P63 was expressed in myoepithelial
cells of malignant adenomyoepithelioma (B) and adenoid cystic carcinoma (E), CD117 was negative in malignant adenomyoepithelioma (C) and
positive in adenoid cystic carcinoma (F). ×100.
Table 1 Reported cases of biphasic malignant adenomyoepithelioma
Reference No. of cases Age (year) Size (cm) Histologic appearance of malignancy Presence of
metastasis
Hayes [5] 3 77 ~ 93 3.2 ~ 14.0 One epithelial-myoepithelial carcinoma with chondrosarcoma 1 lung
One epithelial-myoepithelial carcinoma 1 lost to
follow up
One epithelial-myoepithelial carcinoma/ACC like
Ahmed, et al. [6] 1 71 1.0 Nests and cords of both epithelial and myoepithelial tumor cells None
Qureshi, et al. [10] 1 65 13 Epithelial glandular structures and myoepithelial spindle areas. None
Hungermann, et al. [11] 1 60 Not
reported
Biphasic malignancy with well-developed tubular structures Not
reported
Simpson, et al. [12] 1 50 4.0 Mixed osteogenic, spindle cell, and carcinomatous differentiation Lung
Kiaer, et al. [13] 1 46 2.0 Peripherally proliferating myoepithelial cells and luminally localized
eosinophilic cuboidal and columnar cells.
None
Pauwels, et al. [14] 1 49 Not
reported
A proliferation of tubules composed of epithelial cells surrounded by
myoepithelial cells with high mitotic figures and focal atypia
None
Petrozza, et al. [15] 1 60 2.0 Focal epithelial-like component with high mitotic figures and partial
myoepithelial-like component with atypia and high mitotic figures
None
Rasbridge, et al. [16] 5 39 ~ 76 1.3 ~ 4.5 Contain areas of invasive malignant cells or foci of cellular atypia and
increased mitotic activity.
1 brain
Trojani, et al. [17] 1 51 2.0 Bicellular pattern of epithelial and myoepithelial cells lung
Yang and Wang, et al.
(current case)
1 61 1.6 Epithelial-myoepithelial carcinoma None
ACC: adenoid cystic carcinoma.
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spectrum of hyperplastic and neoplastic lesions character-
ized by dual differentiation into ductal and myoepithelial
cells [4]. There was only one report that adenoid cystic
carcinoma arising in an adenomyoepithelioma in breast
[3], which Hayes commented that “since these neoplasms
are so closely related this is an arguable entity” [5]. How-
ever, the difference does exist between the two entities.
Adenoid cystic carcinoma has a characteristic cribriform
architecture, the formation of true glandular spaces and
pseudolumens, and the histologically distinct invagination
of stroma. It lacks the papillary architecture which is fre-
quently seen in adenomyoepithelioma. The myoepithelial
cells tend to be smaller and more basaloid, and the
arrangement of epithelial and myoepithelial cells is less
irregular than that of adenomyoepithelioma [5,18]. Immu-
nohistologically, CD117 highlights the epithelial cells of
adenoid cystic carcinoma [4,19,20] but is totally negative
in malignant adenomyoepithelioma.
The current case and the only case reported previously
with an ACC focus next to AME mass have their simila-
rities and differences (Table 2). Interestingly, we recently
consulted a case of a 45-year-old female who received a
lumpectomy three years ago with a pathological image of
adenoid cystic carcinoma. The recurrent tumor showed
two components of adenoid cystic carcinoma and malig-
nant adenomyoepithelioma. However, we are not fortu-
nate enough to get the pathological documentation of this
case. Tumors with epithelial-myoepithelial differentiation
are rare in breast but comprise a wide spectrum of lesions
ranging from benign (such as pleomorphic adenoma and
adenomyoepithelioma) to low grade malignant (such
as malignant adenomyoepithelioma and adenoid cystic
carcinoma). Boecker and Buerger have demonstrated the
presence of pluripotent progenitor cells which have the
potential to differentiate into either glandular or myoe-
pithelial cells [21]. It is possible that adenoid cystic carci-
noma and malignant adenomyoepithelioma develop from
the same pluripotent progenitor cells [3], so the separation
for these two morphologically close lesions could be
somewhat arbitrary. They could coexist and even trans-
form to each other under certain conditions.
Though ACC and AME are triple-negative breast can-
cers,which show a poor prognosis when paired with basal-
like transcriptome, hormone receptor negativity status isTable 2 Comparison between the current case and the previo
Sex Age (year) Location Size
Van Dorpe et al. [3] Female 36 Juxta-areolar in
right breast
1.0
Yang et al. (current case) Female 61 Upper-outer quadrant
of right breast
1.6
ACC: adenoid cystic carcinoma; AME: adenomyoepithelioma.not related to poor differentiation and a worse prognosis,
as defined in invasive ductal carcinoma not otherwise spe-
cified (IDC NOS) [22-25]. In addition, compared with
adenoid cystic carcinoma of salivary, although they have
similar morphological and immunological phenotypes and
even the same molecular genetic defect, the t(6;9)(q22–23;
p23–24) translocation [26], the biological behavior of
breast and salivary ACC is different. The former showed
indolent clinical behavior, and the latter showed an ag-
gressive course. Adenoid cystic carcinoma of breast pre-
sents as a localized disease with a low frequency of axillary
lymph node involvement of less than 8%, and rare distant
metastases of fewer than 20% [27-30]. Therefore, most cli-
nicians recommend a breast-conserving surgical therapy
with or without radiotherapy [31]. However, some research
performed grading according to the criteria accepted for
salivary ACC and suggested that grade 3 (solid growth
pattern) may have a higher propensity of recurrence and
metastasis [4]. This result has not been confirmed by long-
term follow-up data. At the same time, AME of breast has
better prognosis comparing with epithelial-myoepithelial
carcinoma of salivary gland [32].Most of the adenomyoe-
pitheliomas of breast behave as benign though rare cases
have metastasized [33]. The behavior of malignant adeno-
myoepithelioma seemed to be related to the grade of the
malignant component and the tumor size [4,5]. In our
case, the component of high grade epithelial-myoepithelial
carcinoma might indicate a high frequency of recurrence
and metastases. To date, there are limited published data
on the biological behavior and long-term clinical outcome
of adenoid cystic carcinoma combining with malignant
adenomyoepithelioma. As a result, it is necessary for the
patient to be closely followed-up and periodically exa-
mined following treatment.
Conclusion
In this paper, we report the case of a rare biphasic ma-
lignant adenomyoepithelioma combining with adenoid
cystic carcinoma in a single mass of a 61-year-old
female. The histological characters of the two tumors
were typical, and the transition from malignant AME to
ACC was gradual. Immunohistochemistry was helpful in
distinguishing these two types of malignant epithelial-
myoepithelial tumors. Although most ACC has a more
favorable clinical outcome, the component of high gradeus case
(cm) Type of AME Proportion ofAME to ACC
Relationship between
AME and ACC
Low-grade AME 1.0: 0.3 A focus of ACC at the edge
of AME penetrated the capsule
Malignant AME 1:1 ACC as a lobule of the mass
combined with malignant AME
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dicate a high frequency of recurrence and metastases.
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